PMID- 22815087 OWN - NLM STAT- MEDLINE DCOM- 20130522 LR - 20240318 IS - 1098-1063 (Electronic) IS - 1050-9631 (Print) IS - 1050-9631 (Linking) VI - 23 IP - 1 DP - 2013 Jan TI - Hyperforin modulates dendritic spine morphology in hippocampal pyramidal neurons by activating Ca(2+) -permeable TRPC6 channels. PG - 40-52 LID - 10.1002/hipo.22052 [doi] AB - The standardized extract of the St. John's wort plant (Hypericum perforatum) is commonly used to treat mild to moderate depression. Its active constituent is hyperforin, a phloroglucinol derivative that reduces the reuptake of serotonin and norepinephrine by increasing intracellular Na(+) concentration through the activation of nonselective cationic TRPC6 channels. TRPC6 channels are also Ca(2+) -permeable, resulting in intracellular Ca(2+) elevations. Indeed, hyperforin activates TRPC6-mediated currents and Ca(2+) transients in rat PC12 cells, which induce their differentiation, mimicking the neurotrophic effect of nerve growth factor. Here, we show that hyperforin modulates dendritic spine morphology in CA1 and CA3 pyramidal neurons of hippocampal slice cultures through the activation of TRPC6 channels. Hyperforin also evoked intracellular Ca(2+) transients and depolarizing inward currents sensitive to the TRPC channel blocker La(3+) , thus resembling the actions of the neurotrophin brain-derived neurotrophic factor (BDNF) in hippocampal pyramidal neurons. These results suggest that the antidepressant actions of St. John's wort are mediated by a mechanism similar to that engaged by BDNF. CI - Copyright (c) 2012 Wiley Periodicals, Inc. FAU - Leuner, Kristina AU - Leuner K AD - Department of Neurobiology, Civitan International Research Center, The University of Alabama at Birmingham, Birmingham, Alabama 35294, USA. leuner@em.uni-frankfurt.de FAU - Li, Wei AU - Li W FAU - Amaral, Michelle D AU - Amaral MD FAU - Rudolph, Stephanie AU - Rudolph S FAU - Calfa, Gaston AU - Calfa G FAU - Schuwald, Anita M AU - Schuwald AM FAU - Harteneck, Christian AU - Harteneck C FAU - Inoue, Takafumi AU - Inoue T FAU - Pozzo-Miller, Lucas AU - Pozzo-Miller L LA - eng GR - P30 NS047466/NS/NINDS NIH HHS/United States GR - P30 HD038985/HD/NICHD NIH HHS/United States GR - R01 NS040593/NS/NINDS NIH HHS/United States GR - R01 NS065027/NS/NINDS NIH HHS/United States GR - P01 HD038760/HD/NICHD NIH HHS/United States GR - NS-065027/NS/NINDS NIH HHS/United States GR - NS40593/NS/NINDS NIH HHS/United States GR - R21 HD074418/HD/NICHD NIH HHS/United States GR - P30 NS057098/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20120720 PL - United States TA - Hippocampus JT - Hippocampus JID - 9108167 RN - 0 (Calcium Channel Blockers) RN - 0 (Plant Extracts) RN - 0 (RNA, Small Interfering) RN - 0 (TRPC Cation Channels) RN - 0 (Terpenes) RN - 0 (Trpc6 protein, rat) RN - 6I3K30563S (Lanthanum) RN - DHD7FFG6YS (Phloroglucinol) RN - RM741E34FP (hyperforin) RN - SY7Q814VUP (Calcium) SB - IM MH - Animals MH - Calcium/metabolism MH - Calcium Channel Blockers/pharmacology MH - Dendritic Spines/*drug effects/metabolism MH - Depression/drug therapy/metabolism MH - Gene Expression/physiology MH - Hippocampus/cytology/drug effects/metabolism MH - Hypericum/*chemistry MH - Lanthanum/pharmacology MH - Organ Culture Techniques MH - Phloroglucinol/*analogs & derivatives/pharmacology MH - Plant Extracts/*pharmacology MH - Pyramidal Cells/*drug effects/metabolism/ultrastructure MH - RNA, Small Interfering/genetics MH - Rats MH - Rats, Sprague-Dawley MH - TRPC Cation Channels/*agonists/antagonists & inhibitors/genetics MH - Terpenes/*pharmacology MH - Transfection PMC - PMC3538039 MID - NIHMS388431 EDAT- 2012/07/21 06:00 MHDA- 2013/05/23 06:00 PMCR- 2014/01/01 CRDT- 2012/07/21 06:00 PHST- 2012/06/19 00:00 [accepted] PHST- 2012/07/21 06:00 [entrez] PHST- 2012/07/21 06:00 [pubmed] PHST- 2013/05/23 06:00 [medline] PHST- 2014/01/01 00:00 [pmc-release] AID - 10.1002/hipo.22052 [doi] PST - ppublish SO - Hippocampus. 2013 Jan;23(1):40-52. doi: 10.1002/hipo.22052. Epub 2012 Jul 20.